Open-Label, Multicenter Study on the Safety, Tolerability, and Efficacy of Simulect in Pediatric Renal Transplant Recipients Receiving Triple Therapy With Cyclosporin, Mycophenolate, and Corticosteroids

Basiliximab is a monoclonal antibody directed to theinterleukin-2 receptor. Several studies have demonstrated both its efficacy and safety. Even with the use of polyclonal antibodies in renal pediatric transplant recipients, the local incidence of steroid-resistant rejections has been close to 10% o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2005-03, Vol.37 (2), p.672-674
Hauptverfasser:	Turconi, A., Rodriguez Rilo, L., Goldberg, J., de Boccardo, G., Garsd, A., Otero, A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - therapeutic use Antibodies, Monoclonal - therapeutic use Biological and medical sciences Biopsy Cadaver Child Cyclosporine - therapeutic use Drug Therapy, Combination Female Fundamental and applied biological sciences. Psychology Fundamental immunology Graft Rejection - pathology Histocompatibility Testing Humans Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Living Donors Male Medical sciences Mycophenolic Acid - therapeutic use Prospective Studies Recombinant Fusion Proteins - therapeutic use Safety Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Tissue Donors Tissue, organ and graft immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!